AlphAIAlphAI — Financial news for AI agents
seekingalpha.comOCT 281 min read$ALGN

Align Technology Non-GAAP EPS of $2.80 beats by $0.04, revenue of $1.01B beats by $10M (ALGN:NASDAQ)

Align Technology reported Q3 Non-GAAP EPS of $2.80, exceeding estimates by $0.04, with revenue of $1.01B, up 1.4% Y/Y and $10M above expectations. Clear Aligner revenues rose 4.2% Y/Y to $839.3M, with volume up 6.6% to 690.6K cases.

Original reporting
seekingalpha.com
Published Oct 28, 2026, 8:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$ALGN
Bullish
high confidence
Mentioned
$ALGN
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$ALGNBullishHigh
01

Why it matters

The beat provides a fresh data point that could drive short-term buying pressure.

02

Market read

Earnings beat is a primary catalyst for the stock and may influence the dental equipment sector.

03

What to watch

Potential headwinds from supply chain constraints or competitive pricing pressure.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

Align Technology released its Q3 2026 earnings, reporting a modest beat on both EPS and revenue.

Company-level read

Ticker impact

$ALGNBullishHigh confidence
Context

Q3 2026 Non-GAAP EPS of $2.80 beats consensus by $0.04 and revenue of $1.01B beats by $10M.

Expected impact

likely upside as market prices in the earnings beat

Evidence & confidence

Both EPS and revenue exceeded expectations, providing a fresh catalyst for buying.

Market effects

Sector

Positive earnings may lift the broader dental/orthodontic equipment sector.

Regional

U.S. market sentiment could improve in the healthcare equipment space.

Global

Limited to U.S. investors; no immediate global macro effect.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face short-term profit taking.

Key entities

  • Company
    Align Technology

    Provider of clear aligner orthodontic solutions.

Read at source← All news

StoryAlign Technology posts Q3 beat but shares slide on weaker Q4 outlook

Also covered by

2 outlets

Related articles

OCT 28
$ALGNHighAI 8/10

Align Technology stock sheds 5% on weak Q4 revenue outlook

Align Technology (ALGN) reported Q3 2026 earnings beating estimates with $2.80 EPS and $1.02B revenue, but shares fell 5% due to Q4 guidance below expectations. Q4 revenue forecasted at $1.00-$1.02B vs. $1.05B consensus. Full-year revenue expected at $4.11-$4.13B vs. $4.15B estimate. Clear Aligner revenues rose 4.2% YoY, while Imaging Systems revenues declined 7.6% YoY.

investing.com2 min
OCT 28
$ALGNLow

Procter & Gamble's former global healthcare CEO will lead Align on Dec. 31.

Align Technology (ALGN) has appointed Jennifer L. Davis, former CEO of Procter & Gamble’s Global Healthcare, as its new President and CEO effective December 31, 2026. Davis brings 33 years of experience in healthcare and consumer brands. Current CEO Joseph M. Hogan will step down but support the transition. The company also released its third-quarter 2026 financial results and will host a conference call.

stocktitan.net2 min
OCT 28
$ALGNHighAI 8/10

Clear-aligner shipments rose 6.6% to 690,635 cases at Align Technology.

Align Technology reported Q3 2026 revenues of $1.015 billion, up 1.9% YoY. Clear Aligner revenues rose 4.2% YoY to $839.3 million, with shipments up 6.6% to 690,635 cases. Imaging Systems and CAD/CAM Services revenues fell 7.6% YoY. Gross margin was 68.7% (70.4% non-GAAP), and operating margin improved to 16.7% (24.4% non-GAAP). The company repurchased 627.3K shares and expects Q4 revenues between $1.020B and $1.000B.

stocktitan.net3 min